Certified by Founder Lodge 
                                        
                                        Farallon Capital Management
 
                                                 United States  -  San Francisco, CA 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $175,000,000
                                            4 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Farallon Capital Management, L.L.C.® is a global institutional asset management firm founded in 1986. We are headquartered in San Francisco and operate globally with offices in London, Singap
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   Metagenomi | 
                                                            January, 25 ,2022 | Series B | $175,000,000 | 
   Beta Bionics | 
                                                            September, 04 ,2023 | Series D | $100,000,000 | 
   Mirador Therapeutics | 
                                                            March, 26 ,2024 | Unknown | $400,000,000 | 
   eGenesis, Inc. | 
                                                            September, 04 ,2024 | Series B | $191,000,000 | 
                                                
  Metagenomi
  Beta Bionics
  Mirador Therapeutics
  eGenesis, Inc.
dezerv.
 
                                            
FalconX
Kristal.AI
 
                                            
Finary
 
                                            
Savart
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)